Saltar al contenido
Merck

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.

Proceedings of the National Academy of Sciences of the United States of America (2000-03-15)
S D Khare, I Sarosi, X Z Xia, S McCabe, K Miner, I Solovyev, N Hawkins, M Kelley, D Chang, G Van, L Ross, J Delaney, L Wang, D Lacey, W J Boyle, H Hsu
RESUMEN

TALL-1/Blys/BAFF is a member of the tumor necrosis factor (TNF) ligand superfamily that is functionally involved in B cell proliferation. Here, we describe B cell hyperplasia and autoimmune lupus-like changes in transgenic mice expressing TALL-1 under the control of a beta-actin promoter. The TALL-1 transgenic mice showed severe enlargement of spleen, lymph nodes, and Peyer's patches because of an increased number of B220+ cells. The transgenic mice also had hypergammaglobulinemia contributed by elevations of serum IgM, IgG, IgA, and IgE. In addition, a phenotype similar to autoimmune lupus-like disease was also seen in TALL-1 transgenic mice, characterized by the presence of autoantibodies to nuclear antigens and immune complex deposits in the kidney. Prolonged survival and hyperactivity of transgenic B cells may contribute to the autoimmune lupus-like phenotype in these animals. Our studies further confirm TALL-1 as a stimulator of B cells that affect Ig production. Thus, TALL-1 may be a primary mediator in B cell-associated autoimmune diseases.